Home
Home

Qsymia

Vivus Taps Into More Cash

Vivus Taps Into More Cash
Seeking Alpha

Will Obesity Drugs Gain Soon?

Will Obesity Drugs Gain Soon?
Motley Fool

Obesity Drug Demand Still Low

Obesity Drug Demand Still Low
Motley Fool

[video]Are Obesity Drugs a Lost Cause in Europe?

[video]Are Obesity Drugs a Lost Cause in Europe?
Motley Fool

Vivus And Anti-Obesity Sector Benefit From New Insurance Deal

Vivus And Anti-Obesity Sector Benefit From New Insurance Deal
Seeking Alpha

Exciting Catalysts Approaching for This Bet

Exciting Catalysts Approaching for This Bet
Motley Fool

Vivus Seeing Traction With Qsymia

Vivus Seeing Traction With Qsymia
Seeking Alpha

Vivus Gets Restrictions Loosened

Vivus Gets Restrictions Loosened; Will Be Available in Retail Pharmacies Later This Year
Seeking Alpha

An Obesity Drugmaker's Critical Coming Weeks

An Obesity Drugmaker's Critical Coming Weeks
Motley Fool

Risk plan change not enough for Vivus drug success: top investor

Risk plan change not enough for Vivus drug success: top investor
Reuters